Valuation Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.220 USD | 0.00% |
|
+4.20% | -48.16% |
Company Valuation: Corbus Pharmaceuticals Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 81.62 | - | - |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | -45.88% | - | - |
| Enterprise Value (EV) | 77.1 | 13.84 | 26.72 | 143.7 | 150.8 | 81.62 | 81.62 | 81.62 |
| Change | - | -82.05% | 93.01% | 437.89% | 4.94% | -45.88% | 0% | 0% |
| P/E | -1.66x | -0.33x | -0.59x | -3.21x | -1.38x | -0.75x | -0.73x | -0.72x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.04x | -0.37x | 0x | -0x | 0.19x | -0.33x | -0.9x |
| Capitalization / Revenue | 87.4x | - | - | - | - | 73.5x | 31.8x | 29.3x |
| EV / Revenue | 0x | - | - | - | - | 73.5x | 31.8x | 29.3x |
| EV / EBITDA | - | - | - | -0x | - | -0.72x | -0.7x | -0.46x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.69x | -0.61x | -0.47x |
| EV / FCF | -0x | -0x | - | -0x | -0x | -0.67x | -0.62x | -0.54x |
| FCF Yield | -62.6% | -271% | - | -29.1% | -42.8% | -148% | -162% | -186% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -11.1 | -10.15 | -10.31 | -3.68 | -5.9 | -5.661 | -5.785 | -5.831 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.8817 | - | - | - | - | 1.111 | 2.567 | 2.789 |
| EBITDA 1 | - | - | - | -48.13 | - | -114 | -117.3 | -179.2 |
| EBIT 1 | -55.99 | -39.84 | -45.08 | -48.72 | -85.31 | -118.5 | -134.5 | -174 |
| Net income 1 | -45.64 | -42.35 | -44.6 | -40.21 | -78.54 | -116.3 | -135 | -170.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.471 | 3.315 | 6.040 | 11.800 | 8.140 | 4.220 | 4.220 | 4.220 |
| Nbr of stocks (in thousands) | 4,174 | 4,176 | 4,424 | 12,179 | 18,529 | 19,341 | - | - |
| Announcement Date | 08/03/22 | 07/03/23 | 12/03/24 | 11/03/25 | 09/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77x | - | - | - | 81.62M | |
| 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 25.36x | 27.05x | 16.29x | 0.34% | 39.28B | |
| Weighted average by Cap. | 27.78x | 25.71x | 16.39x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRBP Stock
- Valuation Corbus Pharmaceuticals Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
